(Q39107511)

English

Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.

scientific article published on 20 August 2013

Statements

Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit